Skip to main content
Clinical Trials/IRCT20170417033490N2
IRCT20170417033490N2
Completed
Phase 3

Evaluation of oral calcium effect versus placebo in the prevention of moderate to severe OHSS (ovarian hyperstimulation syndrome) in the high-risk patients for OHSS

Tehran University of Medical Sciences0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
OHSS(ovarian hyperstimulation syndrome).
Sponsor
Tehran University of Medical Sciences
Enrollment
150
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\- Antagonist protocol for Assisted reproductive technology (ART)
  • 2\- ) 2\- The number of follicles \= 20 mm is over 20\.
  • 3\- The plasma estradiol level \= 2500pg/ml

Exclusion Criteria

  • 1\-patients with the endocrine disease as Diabetes mellitus, hyperprolactinemia, Cushing disease, congenital adrenal hyperplasia
  • 2\- Patients with the systemic disease as asthma, collagen vascular disease, hypercholesterolemia, cycle cell anemia
  • 3\- History of neoplasm
  • 4\-The plasma estradiol level is high (over 6000pg/ml).
  • 5\- Use of insulin\-sensitization drugs
  • 6\- Patients that were required to the need to cycle cancellation.

Outcomes

Primary Outcomes

Not specified

Similar Trials